Neolys Develops Blood Test to Help Doctors Decide Radiotherapy Levels for Prostate Cancer

Neolys Develops Blood Test to Help Doctors Decide Radiotherapy Levels for Prostate Cancer
Neolys Diagnostics has developed a blood test to measure patients' sensitivity to radiation before they receive radiation therapy, a common prostate cancer treatment. The test helps doctors choose a radiation level that a patient's healthy tissue can withstand — so as little damage as possible is done to that tissue. Doctors have had few ways of judging that amount. More than half of prostate cancer patients receive radiotherapy, Neolys said. Although it is effective, a lot of patients experience unwanted side effects and severe damage to normal tissue. Bearing in mind that patients
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *